The relationship between baroreflex sensitivity (BRS) and inflammatory vascular biomarker Lipoprotein associated phospholipase A2 (Lp-PLA2) in subjects with high normal blood pressure (HNBP, prehypertensives) with a positive family history of hypertension (FHH+) and hypertension history free control subjects (FHH-) was evaluated. A total of 24 HNBP participants (age 39.5 ± 2.5 years, 18 male/ 6 female) were studied. 14 HNBP subjects FHH+ were compared to 10 HNBP participants FHH-, being of similar age and body mass index. BRS (ms/mmHg) was determined by the sequence and spectral methods (five-minute non-invasive beat-to-beat recording of blood pressure and RR interval, controlled breathing at a frequency of 0.33 Hz). Venous blood was analyzed for Lp-PLA2 biomarker of vascular inflammation and atherothrombotic activity. A significant negative correlation between spontaneous BRS obtained by both methods and systolic blood pressure (BP) was present (BRS spect r = -0.54, P<0.001, BRS seq r = -0.59, P<0.001). BRS obtained by sequence and spectral methods were reduced in HNBP FHH+ compared to the group of HNBP FHH- (P = 0.0317 BRS seq, P = 0.0395 BRS spect). Lp-PLA2 was significantly higher in HNBP FHH+ compared to FHH- controls (P<0.05). Lp-PLA2 was negatively correlated with BRS obtained by sequence method (r = -0.798, R2 = 0.636, P<0.001) in the HNBP FHH+ subjects. These findings demonstrate that reduced baroreflex sensitivity, as a marker of autonomic dysfunction, is associated with vascular inflammation, predominantly in otherwise healthy participants with a positive family history of hypertension who could predispose to increased risk of hypertension. We conclude that our transversal study suggests that a lowbaroreflex sensitivity could be an early sign of autonomic dysfunction even in the prehypertensive period, and to corroborate these findings, a longitudinal study is needed.

Department of Internal Medicine Faculty of Medicine Comenius University Bratislava Slovak Republic

See more in PubMed

AL KUBATI MAA, FIŠER B, SIEGELOVÁ J. Baroreflex sensitivity during psychological stress. Physiol Res. 1997;46:31–37. PubMed

BIAGGIONI I. Genetic Determinants of Baroreflex Function. In: Robertson D, editor. Primer on the autonomic nervous system. Third Edition. Elsevier; San Diego, USA: 2012. pp. 167–169. DOI

CHAPLEAU MW. Baroreceptor Reflexes. In: Robertson D, et al., editors. Primer on the autonomic nervous system. Third Edition. Elsevier; San Diego, USA: 2012. pp. 161–165. DOI

FONKOUE IT, LE NA, KANKAM ML, daCOSTA D, JONES TN, MARVAR PJ, PARK J. Sympathoexcitation and impaired arterial baroreflex sensitivity are linked to vascular inflammation in individuals with elevated resting blood pressure. Physiol Rep. 2019;7:e 14057. doi: 10.14814/phy2.14057. PubMed DOI PMC

FOROUZANFAR MH, LIU P, ROTH GA, NG M, BIRYUKOV S, MARCZAK L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317:165–182. PubMed

FRANEKOVA J, JABOR A. Markers of cardiovascular risk and their use in the general, unselected patient population (in Slovak) Hypertenze a kardiovaskulárni prevence. 2013;2:38–46.

GRASSI G. Sympathetic neural activity in hypertension and related disease. Am J Hypertens. 2010;23:1052–1060. doi: 10.1038/ajh.2010.154. PubMed DOI

HONZÍKOVÁ N, KRTIČKA A, NOVÁKOVÁ Z, ZÁVODNÁ E. A dampening effect of pulse interval variability on blood pressure variations with respect to primary variability in blood pressure during exercise. Physiol Res. 2003;52:299–309. PubMed

HONZÍKOVÁ N, FIŠER B. Baroreflex sensitivity and essential hypertension in adolescents. Physiol Res. 2009;58:605–612. PubMed

HONZÍKOVÁ N, NOVÁKOVÁ Z, ZÁVODNÁ E, PADĚROVÁ J, LOKAJ P, FIŠER B, BALCÁRKOVÁ P, HRSTKOVÁ H. Baroreflex sensitivity in children, adolescents, and young adults with essential and white-coat hypertension. Klin Padiatr. 2006;218:237–242. doi: 10.1055/s-2005-836596. PubMed DOI

HONZÍKOVÁ N, ZÁVODNÁ E. Baroreflex sensitivity in children and adolescents: physiology, hypertension, obesity, diabetes mellitus. Physiol Res 2. 2016;65:879–889. doi: 10.33549/physiolres.933271. PubMed DOI

IWASE N, TAKATA S, OKUWA H, OGAWA J, IKEDA T, HATTORI N. Abnormal baroreflex control of heart rate in normotensive young subjects with a family history of essential hypertension. J Hypertens. 1984;2(Suppl 2):S409–S411. PubMed

JANSSEN MJA, SWENNE CA, De BIE J, TER HEIDE H. Methods in heart rate variability analysis: may the ventricular or the pulse rhythm be used as a substitute for the atrial rhythm? High Blood Pressure & Cardiovasc Prevent. 1994;3:23–29.

JÍRA M, ZÁVODNÁ E, HONZÍKOVÁ N, NOVÁKOVÁ Z, FIŠER B. Baroreflex sensitivity as an individual characteristic feature. Physiol Res. 2006;53:349–351. PubMed

JÍRA M, ZÁVODNÁ E, HONZÍKOVÁ N, NOVÁKOVÁ Z, VAŠKU A, IZAKOVIČOVÁ HOLLÁ L, FISER B. Association of A1166C polymorphism in AT (1) receptor gene with baroreflex sensitivity. Physiol Res. 2010;59:517–528. PubMed

KRONTORÁDOVÁ K, HONZÍKOVÁ N, FIŠER B, NOVÁKOVÁ Z, ZÁVODNÁ E, HRSTKOVÁ H, HONZÍK P. Overweight and decreased baroreflex sensitivity as independent risk factors for hypertension in children, adolescents and young adults. Physiol Res. 2008;57:385–391. PubMed

LÁBROVÁ R, HONZÍKOVÁ N, MADĚROVÁ E, VYSOČANOVÁ P, NOVÁKOVÁ Z, ZÁVODNÁ E, FIŠER B, SEMRÁD B. Age-dependent relationship between the carotid intima-media thickness, baroreflex sensitivity, and the inter-beat interval in normotensive and hypertensive subjects. Physiol Res. 2005;54:593–600. PubMed

La ROVERE MT, GNEMMI N, VACCARINI C. Baroreflex sensitivity. Ital Heart J. 2001;2:472–477. PubMed

LAZAROVÁ Z, TONHAJZEROVÁ I, TRUNKVALTEROVÁ Z, BROZMANOVÁ A, HONZÍKOVÁ N, JAVORKA K, BAUMERT M, JAVORKA M. Baroreflex sensitivity is reduced in obese normotensive children and adolescents. Can J Physiol Pharmacol. 2009;87:565–571. doi: 10.1139/Y09-041. PubMed DOI

NANDEESHA H, BOBBY Z, SELVARAJ N, RAJAPPA M. Pre-hypertension: is it an inflammatory state? Clin Chim Acta. 2015;451:338–342. doi: 10.1016/j.cca.2015.10.022. PubMed DOI

ORMEZZANO O, CRACOWSKI JL, QUESADA JL, PIERRE H, MALLION JM, BAQUET JP. Evaluation of the prognostic value of baroreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens. 2008;26:1373–1378. doi: 10.1097/HJH.0b013e3283015e5a. PubMed DOI

ORMEZZANO O, POIRIER O, MALLION JM, NICAUD V, AMAR J, CHAMONTIN B, MOUNIER-VÉHIER C, FRANÇOIS P, CAMBIEN F, BAGUET JP. A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens. 2005;23:2019–2026. doi: 10.1097/01.hjh.0000184748.49189.36. PubMed DOI

PERSSON PB. Baroreflexes in hypertension: a mystery revisited. Hypertension. 2005;46:1095–1096. doi: 10.1161/01.HYP.0000187014.92384.a4. PubMed DOI

TANK J, JORDAN J, DIETRICH A, STOFFELS M, FRANKE G, FAULHABER HD, LUFT FC, BUSJAHN A. Genetic influences on baroreflex function in normal twins. Hypertension. 2001;37:907–910. doi: 10.1161/01.HYP.37.3.907. PubMed DOI

WHELTON PK, CAREY RM, ARONOW WS, CASEY DE, COLLINS KJ, DENNISON HIMMELFARB C, DEPALMA SM, GIDDING S, JAMERSON KA, JONES DW, MacLAUGHLIN EJ, MUNTNER P, OVBIAGELE B, SMITH SC, Jr, SPENCER CC, STAFFORD RS, TALER SJ, THOMAS RJ, WILLIAMS KA, SR, WILLIAMSON JD, WRIGHT JT., Jr Guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71:1269–1324. doi: 10.1161/HYP.0000000000000065. PubMed DOI

WILLIAMS B, MANCIA G, SPIERING W, AGABITI ROSEI E, AZIZI M, BURNIER M, CLEMENT DL, COCA A, De SIMONE G, DOMINICZAK A, KAHAN T, MAHFOUD F, REDON J, RUILOPE L, ZANCHETTI A, KERINS M, KJELDSEN SE, KREUTZ R, LAURENT S, LIP GYH, McMANUS R, NARKIEWICZ K, RUSCHITZKA F, SCHMIEDER RE, SHLYAKHTO E, TSIOUFIS C, ABOYANS V, DESORMAIS I AUTHORS/TASK FORCE MEMBERS. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) J Hypertens. 2018;36:1953–2041. doi: 10.1097/HJH.0000000000001940. PubMed DOI